Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,351–3,375 of 7,816 matching trials · page 135 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Improving Wellbeing and Health for Care Home Residents During COVID-19 NCT04590469 COVID WHELD Runs in: United Kingdom · 1 site |
NA other |
WITHDRAWN | 0 | University of Exeter OTHER |
2024-05-22 |
|
Interventions to Attenuate Cognitive Decline: Keys to Staying Sharp NCT03528486 Music Training I Runs in: United States · 1 site |
NA other |
COMPLETED | 268 | University of South Florida OTHER |
2024-05-21 |
|
Effects of Training Dose on Computerized Cognitive Training in Patients With Cognitive Impairment NCT05922319 Computerized cognitive training with different training doses Runs in: China · 1 site |
NA other |
COMPLETED | 21,845 | Xuanwu Hospital, Beijing OTHER |
2024-05-21 |
|
Amyloid PET in Patients With Mild Cognitive Impairment and Early Dementia NCT06402370 PET scan Runs in: Belgium · 1 site |
NA other |
UNKNOWN | 50 | University Hospital, Ghent OTHER |
2024-05-20 |
|
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration NCT00703677 Lithium Runs in: United Kingdom; United States · 9 sites |
PHASE1|PHASE2 other |
COMPLETED | 17 | Westat OTHER |
2024-05-17 |
|
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease NCT03486938 Placebo Oral Tablet; AGB101 220 mg tablet Runs in: Canada; United States · 24 sites |
PHASE2|PHASE3 other |
COMPLETED | 164 | AgeneBio INDUSTRY |
2024-05-17 |
|
CogT pSOPT Intervention Study NCT06005038 pSOPT; MLA Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 50 | Stanford University OTHER |
2024-05-17 |
|
Cognitive Leisure and Preclinical Alzheimer's Disease: Exploring Neural Mechanisms NCT06215274 Relationship of the cognitive leisure activity levels, cognitive fu... Runs in: China · 1 site |
NA other |
RECRUITING | 156 | Yuanjiao Yan OTHER |
2024-05-17 |
|
Effectiveness of Alternative Therapy for Improving Cognition, Balance, and Physical Activity NCT04160299 Dance-based exergaming Runs in: United States · 1 site |
NA other |
COMPLETED | 21 | University of Illinois at Chicago OTHER |
2024-05-16 |
|
Memory and Fear Study (Fear of Memory Loss Study) NCT04821960 Tailored Mindfulness Program for Fear of Memory Loss; Conventional ... Runs in: United States · 1 site |
NA other |
COMPLETED | 81 | Northwestern University OTHER |
2024-05-16 |
|
FOCUS ADHD Mobile Health App for Adult ADHD Patients NCT05551689 Psychostimulant; FOCUS ADHD App Runs in: Brazil · 1 site |
NA other |
COMPLETED | 73 | Hospital de Clinicas de Porto Alegre OTHER |
2024-05-16 |
|
Cultural Pathways to Develop Sustainable Health NCT05635695 Free Museum visit; Cultural pathways App Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 64 | School of Health Sciences Geneva OTHER |
2024-05-16 |
|
Dementia in Migrants Living in Italy: Promoting a Diversity-sensitive Clinical Approach and Provision of Care NCT06416137 Neuropsychological tests |
NA other |
UNKNOWN | 3,000 | Istituto Superiore di Sanità OTHER |
2024-05-16 |
|
Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) NCT06416267 |
NA other |
NOT_YET_RECRUITING | 1,500 | University of Haifa OTHER |
2024-05-16 |
|
A Smart-wrist Band Connected Mobile Application for the Assessment and Management of Dementia Symptoms NCT06417333 xiaomi mi band 7 smart wristband Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 60 | Muğla Sıtkı Koçman University OTHER |
2024-05-16 |
|
MIND Diet and Cognitive Function in Middle-aged and Older Adults NCT06417749 Control arm; Intervention arm Runs in: China · 1 site |
NA other |
UNKNOWN | 1,200 | Zhejiang University OTHER |
2024-05-16 |
|
The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial NCT02525198 fatty acid/flavonoid blend; Placebo Runs in: Australia; United Kingdom; United States · 3 sites |
NA other |
COMPLETED | 259 | University of East Anglia OTHER |
2024-05-14 |
|
Aging Brain Structure and Memory in Response to Exercise NCT03855475 Aerobic exercise; Stretching Runs in: United States · 1 site |
NA other |
COMPLETED | 36 | University of Delaware OTHER |
2024-05-14 |
|
Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment NCT06083350 Yeast beta-glucan; Starch Runs in: China · 2 sites |
NA other |
UNKNOWN | 144 | Xiaofan Xu OTHER |
2024-05-14 |
|
Noradrenergic Add-on Therapy With Guanfacine NCT03116126 Guanfacine; Placebo Runs in: United Kingdom · 1 site |
PHASE3 other |
UNKNOWN | 148 | Imperial College London OTHER |
2024-05-13 |
|
Dexmedetomidine Sublingual Film for the Management of Agitation in Delirium: Safety and Preliminary Efficacy NCT04382170 Dexmedetomidine sublingual film |
PHASE2 other |
WITHDRAWN | 0 | Jeff C. Huffman, MD OTHER |
2024-05-13 |
|
WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease NCT05032482 Non-invasive brainstem stimulation Runs in: United States · 5 sites |
NA other |
WITHDRAWN | 0 | Scion NeuroStim INDUSTRY |
2024-05-13 |
|
Treatment of Periodontal Disease in Patients With Alzheimer's Disease NCT05183321 periodontal therapy |
NA other |
NOT_YET_RECRUITING | 190 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology OTHER |
2024-05-13 |
|
Exploring Racial Disparities in Sleep Health and Neurocognitive Function NCT04015830 electroencephalography (EEG) and event related potentials (ERP) Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | University of Alabama, Tuscaloosa OTHER |
2024-05-10 |
|
Acceptance and Commitment Therapy for Informal Caregivers of People With Dementia NCT05064969 Blended intervention based in acceptance and commitment therapy Runs in: Netherlands · 1 site |
NA other |
COMPLETED | 30 | Maastricht University Medical Center OTHER |
2024-05-10 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial